426 related articles for article (PubMed ID: 17620073)
1. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study.
Jacobsen L; Niggemann B; Dreborg S; Ferdousi HA; Halken S; Høst A; Koivikko A; Norberg LA; Valovirta E; Wahn U; Möller C;
Allergy; 2007 Aug; 62(8):943-8. PubMed ID: 17620073
[TBL] [Abstract][Full Text] [Related]
2. Five-year follow-up on the PAT study: specific immunotherapy and long-term prevention of asthma in children.
Niggemann B; Jacobsen L; Dreborg S; Ferdousi HA; Halken S; Høst A; Koivikko A; Koller D; Norberg LA; Urbanek R; Valovirta E; Wahn U; Möller C;
Allergy; 2006 Jul; 61(7):855-9. PubMed ID: 16792584
[TBL] [Abstract][Full Text] [Related]
3. [Preventive immunotherapy].
Boquete M; Carballada F; Expósito F; González A
Allergol Immunopathol (Madr); 2000; 28(3):89-93. PubMed ID: 10867376
[TBL] [Abstract][Full Text] [Related]
4. Twelve-year follow-up after discontinuation of preseasonal grass pollen immunotherapy in childhood.
Eng PA; Borer-Reinhold M; Heijnen IA; Gnehm HP
Allergy; 2006 Feb; 61(2):198-201. PubMed ID: 16409196
[TBL] [Abstract][Full Text] [Related]
5. Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma.
Roberts G; Hurley C; Turcanu V; Lack G
J Allergy Clin Immunol; 2006 Feb; 117(2):263-8. PubMed ID: 16461125
[TBL] [Abstract][Full Text] [Related]
6. A randomized, controlled study of specific immunotherapy in monosensitized subjects with seasonal rhinitis: effect on bronchial hyperresponsiveness, sputum inflammatory markers and development of asthma symptoms.
Crimi N; Li Gotti F; Mangano G; Paolino G; Mastruzzo C; Vancheri C; Lisitano N; Polosa R
Ann Ital Med Int; 2004; 19(2):98-108. PubMed ID: 15317270
[TBL] [Abstract][Full Text] [Related]
7. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
[TBL] [Abstract][Full Text] [Related]
8. The type of sensitizing allergen can affect the evolution of respiratory allergy.
Marogna M; Massolo A; Berra D; Zanon P; Chiodini E; Canonica GW; Passalacqua G
Allergy; 2006 Oct; 61(10):1209-15. PubMed ID: 16942571
[TBL] [Abstract][Full Text] [Related]
9. High-dose sublingual immunotherapy in children at 8-year follow-up.
Leonardi S; Spicuzza L; La Rosa M
Ann Allergy Asthma Immunol; 2009 Mar; 102(3):259-60. PubMed ID: 19354077
[No Abstract] [Full Text] [Related]
10. Immunotherapy with an extract of Olea europaea quantified in mass units. Evaluation of the safety and efficacy after one year of treatment.
González P; Florido F; Sáenz de San Pedro B; de la Torre F; Rico P; Martín S
J Investig Allergol Clin Immunol; 2002; 12(4):263-71. PubMed ID: 12926186
[TBL] [Abstract][Full Text] [Related]
11. Systemic tolerability of specific subcutaneous immunotherapy with index-of-reactivity-standardized allergen extracts administered using clustered regimens: a retrospective, observational, multicenter study.
Serrano P; Justicia JL; Sánchez C; Cimarra M; Fernández-Távora L; Orovitg A; Moreno C; Guerra F; Alvà V
Ann Allergy Asthma Immunol; 2009 Mar; 102(3):247-52. PubMed ID: 19354072
[TBL] [Abstract][Full Text] [Related]
12. Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis.
Novembre E; Galli E; Landi F; Caffarelli C; Pifferi M; De Marco E; Burastero SE; Calori G; Benetti L; Bonazza P; Puccinelli P; Parmiani S; Bernardini R; Vierucci A
J Allergy Clin Immunol; 2004 Oct; 114(4):851-7. PubMed ID: 15480326
[TBL] [Abstract][Full Text] [Related]
13. An observational study on outgrowing food allergy during non-birch pollen-specific, subcutaneous immunotherapy.
Alonso R; Enrique E; Pineda F; Basagaña M; San Miguel-Moncín MM; Bartra J; Palacios R; Cisteró-Bahíma A
Int Arch Allergy Immunol; 2007; 143(3):185-9. PubMed ID: 17284927
[TBL] [Abstract][Full Text] [Related]
14. Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma.
Kopp MV; Hamelmann E; Zielen S; Kamin W; Bergmann KC; Sieder C; Stenglein S; Seyfried S; Wahn U;
Clin Exp Allergy; 2009 Feb; 39(2):271-9. PubMed ID: 19016798
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of specific immunotherapy with Grazax in allergic rhinitis co-existing with asthma.
Nasser S; Vestenbaek U; Beriot-Mathiot A; Poulsen PB
Allergy; 2008 Dec; 63(12):1624-9. PubMed ID: 19032235
[TBL] [Abstract][Full Text] [Related]
16. Clinical, functional, and immunologic effects of sublingual immunotherapy in birch pollinosis: a 3-year randomized controlled study.
Marogna M; Spadolini I; Massolo A; Canonica GW; Passalacqua G
J Allergy Clin Immunol; 2005 Jun; 115(6):1184-8. PubMed ID: 15940132
[TBL] [Abstract][Full Text] [Related]
17. Long-term efficacy of preseasonal grass pollen immunotherapy in children.
Eng PA; Reinhold M; Gnehm HP
Allergy; 2002 Apr; 57(4):306-12. PubMed ID: 11906360
[TBL] [Abstract][Full Text] [Related]
18. Birch pollen immunotherapy leads to differential induction of regulatory T cells and delayed helper T cell immune deviation.
Möbs C; Slotosch C; Löffler H; Jakob T; Hertl M; Pfützner W
J Immunol; 2010 Feb; 184(4):2194-203. PubMed ID: 20048125
[TBL] [Abstract][Full Text] [Related]
19. Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention.
Halken S
Pediatr Allergy Immunol; 2004 Jun; 15 Suppl 16():4-5, 9-32. PubMed ID: 15125698
[TBL] [Abstract][Full Text] [Related]
20. Clinical trials with recombinant allergens--three perspectives: industry.
Narkus A; Kniest F; Menzel A; Meyer H; Sprung V
Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():270-5; discussion 275-8. PubMed ID: 20799471
[No Abstract] [Full Text] [Related]
[Next] [New Search]
